MENU
RLYB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rallybio (RLYB) Earnings Date & Reports

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

A.I. Advisor
published Earnings

RLYB is expected to report earnings to fall 9.52% to -18 cents per share on November 06

Rallybio RLYB Stock Earnings Reports
Q3'25
Est.
$-0.19
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.55
Q3'24
Beat
by $0.09
Q2'24
Missed
by $0.30
The last earnings report on May 08 showed earnings per share of -20 cents, beating the estimate of -28 cents. With 305.29K shares outstanding, the current market capitalization sits at 21.26M.
View a ticker or compare two or three
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on May 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com